US Phase I Study of ECT-001-CB in Patients With Sickle-Cell Disease

Clinical trial NCT04594031 · WITHDRAWN

Trial details

NCT number: NCT04594031
Sponsor: ExCellThera inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Umbilical Cord Blood Hematopoietic Cell Proliferation

Start date: 2021-07-13
Primary completion: 2023-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.